CanFite Biopharma (CANF)
(Real Time Quote from BATS)
$3.10 USD
+0.03 (0.98%)
Updated Aug 2, 2024 02:41 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/29/2024
Time: -- |
6/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, CanFite Biopharma (CANF) reported earnings of -$0.31 per share, missing the Zacks Consensus Estimate of -$0.27 per share. This reflects a negative earnings surprise of 14.81%. Look out for CANF's next earnings release expected on August 29, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 10%.
Earnings History
Price & Consensus
Zacks News for CANF
Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
CANF: What are Zacks experts saying now?
Zacks Private Portfolio Services